Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 41, Issue 12, 2008, Pages 1029-1035

  Yonekura, K ^a,b   Utsunomiya, A ^a   Takatsuka, Y ^a   Takeuchi, S ^a   Tashiro, Y ^c   Kanzaki, T ^b   Kanekura, T ^b  

^a IMAMURA BUN IN HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Imakiire General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; TACROLIMUS;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CANCER RELAPSE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DONOR LYMPHOCYTE INFUSION; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; GRAFT VERSUS LYMPHOMA EFFECT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SKIN CANCER; SURVIVAL TIME; T CELL LEUKEMIA; T CELL LYMPHOMA;

ADULT; COHORT STUDIES; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SKIN DISEASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 47849109345     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.39     Document Type: Article

References (27)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 1977; 50: 481-492.
2. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K et al. Adult T-cell leukemia: Antigen in an ATL cell fine and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-6480.
3. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031-2035.
4. Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K et al Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J Clin Oncol 1998; 6: 128-141.
5. Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M et al A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375-392.
6. Tsukasaki K, Maeda T, Arimura K, Taguchi J, Fukushima T, Miyazaki Y et al. Poor outcome of autologous stem cell transplantation for adult T-cell leukemiapymphoma: A case report and review of the literature. Bone Marrow Transplant 1999; 23: 87-89.
7. Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 15-20.
8. Kami M, Hamaki T, Miyakoshi S, Murashige N, Kanda Y, Tanosaki R et al Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 2003; 120: 30430-30439.
9. Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 2005; 105: 4143-4145.
10. Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/ lymphoma. Leukemia 2005; 19: 829-834.
11. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-1987). Br J Haematol 1991; 79: 428-437.
12. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beaty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
13. Ishida T, Utsunomiya A, Iida. S, Inagaki H, Takatsuka Y, Kusumoto S et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: Its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003; 9: 3625-3634.
14. Ishida T, Iida S, Akatsuka Y, Ishii T, Miyazaki M, Komatsu H et al The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin Cancer Res 2004; 10: 7529-7539.
15. Narducci MG, Scala E, Bresin A, Caprini E, Picchio MC, Remotti D et al. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidyl-peptidase IV. Blood 2066; 107: 1108-1115.
16. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281-285.
17. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
18. Koeppel MC, Stoppa AM, Resbeut M, Blaise D, Coignet M, Coulier L et al. Mycosis fungoides and allogenic bone marrow transplantation. Acta Derm Venereol 1994; 74: 331-332.
19. Guitart J, Wickless SC, Oyama Y, Kuzel TM, Rosen ST, Traynor A et al Long-term remission after allogeneic hematopoictic: Stem cell transplantation for refractory cutaneous T-cell lymphoma. Arch Dermatol 2002; 138: 1359-1365.
20. Soligo D, Ibatici A, Berti E, Morandi P, Longhi E, Venegoni L et al Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen. Bone Marrow Transplant 2003; 31: 663-666.
21. Herbert KE, Spencer A, Grigg A, Ryan G, McCormack C, Prince HM. Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 34: 521-525.
22. Molina A, Nademanee A, Arber DA, Forman SJ. Remission of refractory Sézary syndrome after bone marrow transplantation from a matched unrelated donor. Biol Blood Marrow Transplant 1999; 5: 400-404.
23. Burt RK, Guitart J, Traynor A, Link C, Rosen S, Pandolfino T et al Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: Evidence of a graft-versus-tumor effect. Bone Marrow Transplant 2000; 25: 111-113.
24. Masood N, Russell KJ, Olerud JE, Sabath DE, Sale GE, Doney KC et al Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation. J Am Acad Dermatol 2002; 47: 140-145.
25. Fijnheer R, Sanders CJ, Canninga MR, de Weger RA, Verdonck LF. Complete remission of a radiochemotherapy-resistant cutaneous T-cell lymphoma with allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant 2003; 32: 345-347.
26. Molina A, Zain J, Arber DA, Angelopolou M, O'Donnell M, Murata-Collins J et al. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sézary syndrome and mycosis fungoides. J Clin Oncol 2005; 23 6163-6171.
27. Ferrara JL, Deeg HJ, Division of Pediatric Oncology D-FCIBMA. Graft-versus-host disease. N Engl J Med 1991; 324: 667-674.